TipRanks
Go Ultimate55% OFF

AngioDynamics (ANGO) Q3 2026 Earnings Report

ANGO Q3 2026 EPS Results

Actual EPS
$0.02
Consensus EPS
-$0.11
Beat/Miss
Beat by +$0.13
One Year Ago EPS
-$0.08

ANGO Q3 2026 Revenue Results

Actual Revenue
$78.42M
Expected Revenue
$76.77M
Beat/Miss
Beat by +$1.66M
YoY Revenue Growth
+8.91%

Earnings Announcement Details

Quarter
Q3 2026
Date
04/02/2026
Time
Before Open
Conference Call
Thursday, April 2, 2026
ANGO Upcoming Earnings

AngioDynamics's next earnings date is estimated for January 7, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Audio

ANGO Q3 2026 Earnings Call
0:00 / 0:00

Q3 2026 Earnings Slide Deck

Q3 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

ANGO Earnings History

ANGO earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Jan 07, 20272027 (Q2)-0.07-0――
Oct 08, 20262027 (Q1)-0.11-0.04-0.160.00% (+0.06)
Jul 14, 20262026 (Q4)-0.09-0.07-0.03-133.33% (-0.04)
Apr 02, 20262026 (Q3)-0.110.02-0.08125.00% (+0.10)
Jan 06, 20262026 (Q2)-0.100.00-0.04100.00% (+0.04)
Oct 02, 20252026 (Q1)-0.12-0.10-0.119.09% (+0.01)
Jul 15, 20252025 (Q4)-0.12-0.03-0.0650.00% (+0.03)
Apr 02, 20252025 (Q3)-0.13-0.08-0.1650.00% (+0.08)
Jan 08, 20252025 (Q2)-0.11-0.04-0.0520.00% (+0.01)
Oct 03, 20242025 (Q1)-0.15-0.11-0.128.33% (+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed
Show More